Procurement Summary
Country: Brazil
Summary: Intention to Register Prices for Future and Possible Acquisition of Medicines (Injectables) 02 - Intention Rp 089/2026 (For all Items, the Descriptions Available on Compras Net Differ from T...
Deadline: 16 Jul 2026
Posting Date: 01 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144346790
Document Ref. No.: 90192/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Intention to Register Prices for future and possible ACQUISITION OF MEDICINES (INJECTABLES) 02 - INTENTION RP 089/2026 (FOR ALL ITEMS, THE DESCRIPTIONS AVAILABLE ON COMPRAS NET DIFFER FROM THE TERMS OF REFERENCE, CONSIDER FOR PRESENTATION OF ITEMS THE TERMS OF REFERENCE OF THIS CERTIFICATE, AS PUBLICATION ON THE NOTICE BOARD). UASG code: 925998 Notice from: 07/01/2026 from 08:00 to 14:00 Proposal Delivery: from 07/01/2026 at 08:00 NEOSTIGMIN METHYLSULPHATE, DOSAGE 0.5 MG/ML, INJECTABLE SOLUTION PRESENTATION Quantity: 18912 HEPARIN SODIUM, DOSAGE 5, 000UI/ML, INJECTABLE INDICATION Quantity: 113373 HEPARIN SODIUM, DOSAGE 5, 000UI/ML, INJECTABLE INDICATION Quantity: 9411 HEPARIN SODIUM, DOSAGE 5, 000UI/ML, INJECTABLE INDICATION Quantity: 27261 HEPARIN SODIUM, DOSAGE 5, 000UI/ML, INJECTABLE INDICATION Quantity: 4113 TROMETAMOL, KETOROLAC SALT COMPOSITION, CONCENTRATION 30 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 26172 TROMETAMOL, COMPOSITION KETOROLAC SALT, CONCENTRATION 30 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 8724 ALPROSTADIL, DOSAGE 20 MCG, INJECTABLE INDICATION Quantity: 8845 ALPROSTADIL, DOSAGE 20 MCG, INJECTABLE INDICATION Quantity: 851 RADIOLOGICAL CONTRAST, PRESENTATION BASED ON IOBITRIDOL, DOSAGE 65.81% WITH 300MG IODINE/ML, ADDITIONAL CHARACTERISTICS INJECTABLE Quantity: 36000 RADIOLOGICAL CONTRAST, IOBITRIDOL-BASED PRESENTATION, DOSAGE 65.81% WITH 300MG IODE/ML, ADDITIONAL CHARACTERISTICS INJECTABLE Quantity: 792 CYANOCOBALAMIN, COMPOSITION ASSOCIATED WITH PYRIDOXINE AND THIAMINE, CONCENTRATION 5MG + 100 MG + 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 21690 CYANOCOBALAMIN, COMPOSITION ASSOCIATED WITH PYRIDOXINE AND THIAMINE, CONCENTRATION 5MG + 100 MG + 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 7230br...
Documents
Tender Notice